Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Income Statement
Earnings Waterfall
Changzhou Qianhong Biopharma Co Ltd
Revenue
|
2.1B
CNY
|
Cost of Revenue
|
-1.3B
CNY
|
Gross Profit
|
849.3m
CNY
|
Operating Expenses
|
-596.5m
CNY
|
Operating Income
|
252.8m
CNY
|
Other Expenses
|
25.4k
CNY
|
Net Income
|
252.9m
CNY
|
Income Statement
Changzhou Qianhong Biopharma Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
907
N/A
|
861
-5%
|
832
-3%
|
791
-5%
|
807
+2%
|
815
+1%
|
771
-5%
|
744
-4%
|
730
-2%
|
757
+4%
|
750
-1%
|
789
+5%
|
773
-2%
|
776
+0%
|
863
+11%
|
931
+8%
|
995
+7%
|
1 066
+7%
|
1 160
+9%
|
1 223
+5%
|
1 312
+7%
|
1 322
+1%
|
1 350
+2%
|
1 490
+10%
|
1 462
-2%
|
1 675
+15%
|
1 454
-13%
|
1 487
+2%
|
1 694
+14%
|
1 668
-2%
|
1 913
+15%
|
1 886
-1%
|
1 873
-1%
|
1 875
+0%
|
2 036
+9%
|
2 139
+5%
|
2 155
+1%
|
2 304
+7%
|
2 360
+2%
|
2 223
-6%
|
2 121
-5%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(548)
|
(497)
|
(466)
|
(407)
|
(384)
|
(337)
|
(301)
|
(262)
|
(246)
|
(248)
|
(251)
|
(278)
|
(275)
|
(274)
|
(345)
|
(403)
|
(463)
|
(516)
|
(596)
|
(644)
|
(687)
|
(676)
|
(707)
|
(807)
|
(768)
|
(881)
|
(767)
|
(772)
|
(898)
|
(877)
|
(1 035)
|
(1 027)
|
(1 043)
|
(1 041)
|
(1 175)
|
(1 274)
|
(1 307)
|
(1 415)
|
(1 472)
|
(1 343)
|
(1 271)
|
|
Gross Profit |
359
N/A
|
364
+1%
|
366
+1%
|
384
+5%
|
423
+10%
|
478
+13%
|
470
-2%
|
482
+2%
|
484
+0%
|
509
+5%
|
499
-2%
|
511
+2%
|
499
-2%
|
502
+1%
|
518
+3%
|
528
+2%
|
532
+1%
|
550
+3%
|
564
+3%
|
580
+3%
|
626
+8%
|
646
+3%
|
643
0%
|
683
+6%
|
693
+1%
|
794
+15%
|
687
-13%
|
715
+4%
|
796
+11%
|
791
-1%
|
878
+11%
|
859
-2%
|
830
-3%
|
834
+0%
|
861
+3%
|
865
+0%
|
848
-2%
|
889
+5%
|
887
0%
|
880
-1%
|
849
-3%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(215)
|
(220)
|
(222)
|
(224)
|
(245)
|
(294)
|
(276)
|
(271)
|
(276)
|
(312)
|
(300)
|
(310)
|
(329)
|
(347)
|
(352)
|
(357)
|
(373)
|
(425)
|
(416)
|
(451)
|
(488)
|
(515)
|
(511)
|
(535)
|
(549)
|
(588)
|
(586)
|
(582)
|
(573)
|
(951)
|
(949)
|
(988)
|
(959)
|
(619)
|
(614)
|
(629)
|
(683)
|
(656)
|
(586)
|
(594)
|
(596)
|
|
Selling, General & Administrative |
(212)
|
(171)
|
(219)
|
(223)
|
(246)
|
(233)
|
(276)
|
(268)
|
(271)
|
(262)
|
(299)
|
(308)
|
(328)
|
(291)
|
(348)
|
(357)
|
(375)
|
(343)
|
(419)
|
(453)
|
(464)
|
(436)
|
(468)
|
(473)
|
(489)
|
(506)
|
(528)
|
(528)
|
(528)
|
(865)
|
(890)
|
(928)
|
(897)
|
(528)
|
(549)
|
(560)
|
(614)
|
(553)
|
(556)
|
(564)
|
(515)
|
|
Research & Development |
0
|
(42)
|
0
|
0
|
0
|
(53)
|
0
|
0
|
0
|
(41)
|
0
|
0
|
0
|
(44)
|
0
|
0
|
0
|
(64)
|
0
|
0
|
(20)
|
(54)
|
(48)
|
(66)
|
(67)
|
(53)
|
(64)
|
(61)
|
(55)
|
(56)
|
(68)
|
(68)
|
(70)
|
(61)
|
(71)
|
(74)
|
(75)
|
(79)
|
(98)
|
(99)
|
(94)
|
|
Depreciation & Amortization |
0
|
(7)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(34)
|
0
|
0
|
0
|
(36)
|
0
|
0
|
0
|
(38)
|
0
|
0
|
0
|
(39)
|
0
|
0
|
0
|
(34)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(3)
|
(1)
|
(3)
|
(1)
|
1
|
(1)
|
0
|
(2)
|
(4)
|
(1)
|
(2)
|
(3)
|
(1)
|
(2)
|
(4)
|
(0)
|
3
|
3
|
3
|
2
|
(4)
|
9
|
5
|
3
|
6
|
7
|
6
|
8
|
9
|
8
|
8
|
9
|
8
|
9
|
6
|
6
|
7
|
10
|
68
|
68
|
12
|
|
Operating Income |
144
N/A
|
144
0%
|
145
+1%
|
160
+11%
|
178
+11%
|
184
+3%
|
194
+5%
|
211
+9%
|
208
-1%
|
197
-5%
|
198
+1%
|
200
+1%
|
170
-15%
|
155
-9%
|
166
+7%
|
171
+3%
|
159
-7%
|
125
-22%
|
149
+19%
|
128
-14%
|
138
+8%
|
131
-5%
|
133
+1%
|
148
+12%
|
144
-2%
|
206
+43%
|
101
-51%
|
133
+32%
|
222
+67%
|
(160)
N/A
|
(72)
+55%
|
(129)
-80%
|
(130)
0%
|
214
N/A
|
247
+15%
|
236
-4%
|
165
-30%
|
233
+41%
|
301
+29%
|
286
-5%
|
253
-11%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
62
|
66
|
69
|
70
|
77
|
85
|
94
|
91
|
94
|
102
|
105
|
111
|
109
|
107
|
100
|
95
|
92
|
89
|
84
|
102
|
116
|
122
|
125
|
123
|
118
|
94
|
73
|
41
|
(2)
|
(4)
|
(4)
|
(10)
|
5
|
(5)
|
(12)
|
41
|
71
|
70
|
67
|
33
|
0
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
57
|
0
|
0
|
58
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
11
|
7
|
7
|
6
|
7
|
17
|
17
|
18
|
15
|
4
|
9
|
3
|
4
|
4
|
0
|
4
|
3
|
2
|
1
|
4
|
4
|
1
|
2
|
0
|
0
|
1
|
(2)
|
(2)
|
(3)
|
(4)
|
(2)
|
(2)
|
(3)
|
0
|
58
|
58
|
58
|
0
|
(58)
|
(58)
|
(34)
|
|
Pre-Tax Income |
216
N/A
|
216
0%
|
221
+2%
|
237
+7%
|
263
+11%
|
286
+9%
|
305
+7%
|
320
+5%
|
316
-1%
|
303
-4%
|
312
+3%
|
314
+1%
|
282
-10%
|
265
-6%
|
266
+0%
|
269
+1%
|
253
-6%
|
214
-16%
|
233
+9%
|
233
+0%
|
257
+10%
|
254
-1%
|
259
+2%
|
270
+4%
|
262
-3%
|
301
+15%
|
171
-43%
|
172
+0%
|
218
+27%
|
(169)
N/A
|
(78)
+54%
|
(142)
-82%
|
(127)
+10%
|
209
N/A
|
292
+40%
|
335
+15%
|
295
-12%
|
360
+22%
|
311
-14%
|
261
-16%
|
277
+6%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(35)
|
(35)
|
(35)
|
(38)
|
(39)
|
(44)
|
(50)
|
(52)
|
(53)
|
(41)
|
(40)
|
(43)
|
(37)
|
(40)
|
(41)
|
(43)
|
(41)
|
(39)
|
(45)
|
(41)
|
(45)
|
(43)
|
(43)
|
(48)
|
(46)
|
(44)
|
(29)
|
(27)
|
(36)
|
22
|
12
|
22
|
27
|
(23)
|
(35)
|
(38)
|
(35)
|
(40)
|
(33)
|
(23)
|
(27)
|
|
Income from Continuing Operations |
182
|
182
|
186
|
199
|
224
|
242
|
256
|
268
|
264
|
262
|
272
|
271
|
246
|
225
|
225
|
226
|
212
|
175
|
188
|
192
|
212
|
211
|
216
|
222
|
217
|
257
|
143
|
145
|
182
|
(148)
|
(66)
|
(120)
|
(100)
|
186
|
258
|
297
|
260
|
320
|
278
|
238
|
250
|
|
Income to Minority Interest |
6
|
5
|
6
|
7
|
2
|
3
|
3
|
2
|
4
|
5
|
5
|
6
|
4
|
(0)
|
0
|
(1)
|
(0)
|
8
|
8
|
10
|
11
|
10
|
10
|
11
|
15
|
6
|
5
|
7
|
6
|
16
|
14
|
14
|
12
|
(5)
|
(3)
|
(3)
|
0
|
4
|
3
|
3
|
3
|
|
Net Income (Common) |
188
N/A
|
187
0%
|
192
+2%
|
205
+7%
|
226
+10%
|
245
+8%
|
259
+6%
|
270
+4%
|
268
-1%
|
267
0%
|
277
+4%
|
277
+0%
|
250
-10%
|
225
-10%
|
225
+0%
|
226
+0%
|
212
-6%
|
183
-14%
|
197
+7%
|
203
+3%
|
222
+10%
|
221
0%
|
227
+2%
|
233
+3%
|
232
0%
|
263
+13%
|
148
-44%
|
151
+2%
|
188
+24%
|
(132)
N/A
|
(52)
+60%
|
(107)
-104%
|
(88)
+17%
|
181
N/A
|
255
+41%
|
294
+15%
|
260
-12%
|
323
+25%
|
281
-13%
|
241
-14%
|
253
+5%
|
|
EPS (Diluted) |
0.15
N/A
|
0.15
N/A
|
0.16
+7%
|
0.17
+6%
|
0.18
+6%
|
0.19
+6%
|
0.2
+5%
|
0.21
+5%
|
0.21
N/A
|
0.42
+100%
|
0.21
-50%
|
0.21
N/A
|
0.19
-10%
|
0.18
-5%
|
0.18
N/A
|
0.18
N/A
|
0.17
-6%
|
0.14
-18%
|
0.16
+14%
|
0.16
N/A
|
0.18
+13%
|
0.17
-6%
|
0.18
+6%
|
0.19
+6%
|
0.19
N/A
|
0.21
+11%
|
0.12
-43%
|
0.12
N/A
|
0.15
+25%
|
-0.1
N/A
|
-0.04
+60%
|
-0.08
-100%
|
-0.07
+13%
|
0.15
N/A
|
0.2
+33%
|
0.23
+15%
|
0.2
-13%
|
0.25
+25%
|
0.22
-12%
|
0.19
-14%
|
0.2
+5%
|